Search Results - oleg+alekseev

3 Results Sort By:
Use of plasma-treated liquids to treat herpes keratitis
PAGE TITLEOverviewPAGE SUMMARY Drexel researchers have shown that non-thermal dielectric barrier discharge (DBD) plasma treatment is a viable method for reducing herpes simplex virus infection and replication without significantly affecting host cells, making it an ideal treatment for herpes keratitis of the cornea.APPLICATIONSTITLE: ApplicationsPreventing...
Published: 5/19/2022   |   Inventor(s): Jane Clifford, Oleg Alekseev, Kelly Donovan
Keywords(s):  
Category(s): Plasma, Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Infectious Disease, Plasma > Plasma: Liquid Treatment
Compositions Useful for Treating Herpes Simplex Labialis and/or Herpes Esophagitis, and Methods Using Same
PAGE TITLEOverview PAGE SUMMARY The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex labialis or herpes esophagitis, in a subject. In certain embodiments, the compositions of the invention comprise an ATM inhibitor and an anti-herpetic...
Published: 5/19/2022   |   Inventor(s): Jane Clifford, Oleg Alekseev, William Donegan
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Infectious Disease
Compositions Useful for Treating Herpes Simplex Keratitis, and Methods Using Same
PAGE TITLEOverviewPAGE SUMMARY Drexel researchers have discovered a new mechanism to suppress or limit herpes keratitis (HK) infection and related blindness in HK patients. This mechanism operates unlike current treatments in the industry, suppresses viral replication more than polymerase inhibitors alone, and is less likely to lead to viral resistance.APPLICATIONSTITLE:...
Published: 5/19/2022   |   Inventor(s): Jane Clifford, Oleg Alekseev, Stephen Jennings
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Infectious Disease